How Does Rituximab for Pemphigus Fare in the Long Term? : vi

This marks the first long-term follow-up data from patients in the Ritux 3 trial who received rituximab as a first-line agent.

Related Keywords

France , Rouen , Haute Normandie , French , Billal Tedbirt , Department Of Dermatology , Biologic Therapy , Iologics , Antineoplastic Drug , Nti Cancer Agents , Rlotinib , Efitinib , Matinib , Ituximab , U11248 , Unitinib , Rastuzumab , Monoclonal Antibody , Etuximab , Remission , Corticosteroid , Grant ,